Here are relevant reports on : rare-earth-element-market
-
Marine Mining Market by Technology (Remotely Operated Vehicles (ROVs), Sonar, Marine Seismic Methods), Element (Polymetallic Nodules, Polymetallic Sulphides, Cobalt-rich ferromanganese crusts, and Others), Application, and Region - Global Forecast to 2029
The marine mining market is estimated to grow from USD 3.7 billion in 2024 to USD 15.9 billion by 2029, at a CAGR of 33.7%.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) and Region - Global Forecast to 2027
The precast concrete market is expected to grow from USD 144.6 billion in 2022 to USD 198.9 billion by 2027, at a CAGR of 6.6% during the forecast period. Cemex S.A.B de C.V. (Mexico), Boral Limited (Australia), LafargeHolcim Ltd. (Switzerland), Balfour Beatty plc (UK), CRH Plc (UK), Skanska AB (Sweden), Forterra, Inc. (US), DeVinci Precast (US), Atco Concrete Products N.V. (Netherlands), Beaver Gulf Precast Concrete (Dubai), are the key players operating in the precast concrete market. Acquisitions, expansions, contracts, agreements & partnerships, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the precast concrete market.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Autoclaved Aerated Concrete (AAC) Market by Element (Blocks, Beams & Lintels, Cladding Panels, Wall Panels, Roof Panels, Floor Elements), End-use Industry (Residential, Non-Residential), and Region - Global Forecast to 2025
The Autoclaved Aerated Concrete (AAC) Market is expected to grow from USD 18.8 billion in 2020 to USD 25.2 billion by 2025, at a CAGR of 6.0% during the forecast period. Major players operating in the global AAC market include Buildmate Projects Pvt. Ltd. (India), Biltech Building Elements Limited (India), AKG Gazbeton (Turkey), Aercon Florida Llc (US), Solbet Sp Z.O.O. (Poland), UAL Industries Ltd (India), H+H International A/S (Denmark), JK Lakshmi Cement (India), Xella Group (Germany), CSR Ltd. (Australia), UltraTech Cement Ltd. (India), Quinn Building Products (UK), Bauroc International AS (Estonia), and Wehrhahn GmbH (Germany).
- Published: June 2020
- Price: $ 4950
- TOC Available:
-
Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) & Region - Global Forecasts to 2024
The global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Rare Gases Market By Type (Neon, Xenon, Krypton), End-Use (Manufacturing & Construction, Electronics, Automotive, Healthcare), by Transportation Mode (Cylinders, Tonnage Distribution, Bulk Delivery), by Function (Illumination, Insulation) & by Region - Forecast to 2020
The Rare Gases Market is projected to reach USD 380.9 Million by 2020, at a CAGR of 7.68%, from 2015. Growth in construction, lighting, and laser applications, increasing energy prices, and rapid urbanization has fueled the growth of the rare gases market. The illumination segment held the largest share of the total rare gases market in 2014, especially in emerging markets such as China, Brazil, and India.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Therapeutics Market by Molecule (Nusinersen, Vutrisiran, Inclisiran, Eteplisiran), Type (ASO, siRNA, Others), Disease Type (Neurology, Rare Diseases, Others), RoA (SC, Intrathecal, IV, Others), and Region - Global Forecast to 2030
The global oligonucleotide therapeutics market, valued at US$5.92 billion in 2024, stood at US$7.19 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2025 to 2030, culminating in a forecasted valuation of US$17.70 billion by the end of the period. The market is growing as more RNA-targeting therapies gain broader clinical acceptance. This increase is mainly driven by siRNAs and antisense candidates, supported by advances in delivery technologies like GalNAc conjugates and lipid nanoparticles.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
mRNA Therapeutics Market by Product (Vaccines, Drugs), Application (Oncology, Rare Diseases, Infectious Diseases, Other Applications), End User (Hospitals & Clinics, Research Settings) - Global Forecast to 2027
The global mRNA therapeutics market is projected to reach USD ~35 billion by 2027 from USD 32 billion in 2022, at a CAGR of ~2% between 2022 and 2027.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Oligonucleotide Synthesis Market by Product ((Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type ((Custom, Predesigned), Reagents, Equipment), Application (Therapeutic (Rare Diseases), Research, Diagnostics) - Global Forecast to 2030
The global oligonucleotide synthesis market, valued at US$8.9 billion in 2024, stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 18.6% from 2025 to 2030, culminating in a forecasted valuation of US$24.7 billion by the end of the period. The oligonucleotide synthesis market is experiencing significant growth, driven by the increasing applications of synthesized oligonucleotides in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Precision Diagnostics & Medicine Market by Diagnostic Testing (Genetic, DTC), Diagnostics Indication (Oncology, Neurology, Immunology), Therapeutic Products (Inhibitors, mAbs, CGT), Indication (Oncology, Rare Disease, Infectious) - Global Forecast to 2029
The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, stood at US$145.53 billion in 2024 and is projected to advance at a resilient CAGR of 11.1% from 2024 to 2029, culminating in a forecasted valuation of US$246.66 billion by the end of the period. Factors such as the growing integration of AI and ML to enhance precision diagnostics and medicine development supported by rising collaborations between pharmaceutical and diagnostics companies to improve precision healthcare and the rise in direct-to-consumer testing are driving the growth in the market.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020
The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.
- Published: October 2015
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
